VivoSeq
Other

Blood Pressure Variability

0

Pipeline Programs↗

1

Active Trials↗

0

Companies Involved↗

Blood Pressure Variability is an early-stage landscape with 0 programs across 0 companies.

Intelligence

Pipeline Metrics

Competitive Density

6/100

Pipeline Velocity

6/100

Mech. Concentration

N/A

Completion Rate

100/100

Attrition Rate

0/100

Pipeline

Programs by Phase

No pipeline programs currently tracked for this disease.

Analysis

Trial Status

7

clinical trials

Unknown status4 · 57%
Completed2 · 29%
Not yet recruiting1 · 14%

Clinical Trials

Trial Activity

7 trials

Correlates and Control of Blood Pressure Variability
Not yet recruiting·—·Phase 1·NCT06012487·10 enrolled
Carbidopa for the Treatment of Excessive Blood Pressure Variability
Completed·NNYU Langone Health·Phase 2·NCT02553265·22 enrolled
Comparision of Blood Pressure Variability Between Amlodipine and Losartan
Completed·WWonju Severance Christian Hospital·Phase 4·NCT01964079·144 enrolled
The Effects of Nifedipine and Metoprolol on Blood Pressure Variability in Northern Chinese
Unknown status·FFirst Affiliated Hospital of Harbin Medical University·Phase 2/3·NCT02513927·40 enrolled
The Effect of Nitrendipine/Atenolol Combination on Blood Pressure Variability.
Unknown status·SShanghai Jiao Tong University School of Medicine·Phase 4·NCT04931108·32 enrolled
The Effects of Doxazosin and Nifedipine on Blood Pressure Variability and Uric Acid in Plasma in Hypertensive Patients
Unknown status·FFirst Affiliated Hospital of Harbin Medical University·Phase 2/3·NCT02563405·30 enrolled
Effect of Lacidipine and Losartan on 24 Hour Systolic Blood Pressure Variability in Elderly Hypertensive Patients
Unknown status·SSeoul National University Hospital·Phase 4·NCT00533858·160 enrolled

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)